Brenus Pharma has been invited to present its unique STC technology of allogeneic cell-based immune-therapy at the SACHS Immuno Oncology Innovation Forum in the Last Trends in C&G therapeutics session”.
See more here.
Brenus Pharma has been invited to present its unique STC technology of allogeneic cell-based immune-therapy at the SACHS Immuno Oncology Innovation Forum in the Last Trends in C&G therapeutics session”.
See more here.
La semaine collaborative de Lyonbiopôle a mis à l’honneur des pépites biotech… Read More »
As in previous editions, the French Cancer Society (SFC) is working alongside… Read More »
Brenus Pharma has been selected to participate to HTID-Paris 2020 and got… Read More »